Recommendation ID
NG23/10
Question

For people with a personal history of breast cancer, or at high familial or genetic risk of breast cancer, does vaginal oestrogen for genitourinary symptoms associated with menopause increase the risk of recurrence or incidence of breast cancer?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation for research, see the 

Full details of the evidence and the committee's discussion are in in evidence review B2: managing genitourinary symptoms (breast cancer recurrence).


Source guidance details

Comes from guidance
Menopause: identification and management
Number
NG23
Date issued
November 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 28/01/2025